These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen. Mahler M; Fritzler MJ; Satoh M Autoimmun Rev; 2015 Mar; 14(3):254-7. PubMed ID: 25462581 [TBL] [Abstract][Full Text] [Related]
7. Serological profile and clinical features of nucleolar antinuclear pattern in patients with systemic lupus erythematosus from southwestern Spain. Cabrera CM; Fernández-Grande E; Urra JM Lupus; 2016 Aug; 25(9):980-7. PubMed ID: 26846693 [TBL] [Abstract][Full Text] [Related]
8. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365 [TBL] [Abstract][Full Text] [Related]
9. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. Harvey G; Black C; Maddison P; McHugh N J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652 [TBL] [Abstract][Full Text] [Related]
10. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Reimer G; Steen VD; Penning CA; Medsger TA; Tan EM Arthritis Rheum; 1988 Apr; 31(4):525-32. PubMed ID: 2451921 [TBL] [Abstract][Full Text] [Related]
11. [Autoantibodies and their clinical characteristics in systemic sclerosis]. Hamaguchi Y Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071 [TBL] [Abstract][Full Text] [Related]
12. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. Hamaguchi Y J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839 [TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach]. Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of anti-nucleolar antibodies detected by immunoprecipitation method in patients with systemic sclerosis]. Kuwana M; Mimori T; Hama N; Kaburaki J; Okano T; Tojo T Ryumachi; 1992 Feb; 32(1):39-46. PubMed ID: 1604415 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review. Dima A; Vonk MC; Garaiman A; Kersten BE; Becvar R; Tomcik M; Hoffmann-Vold AM; Castellvi I; Jaime JT; Brzosko M; Milchert M; Krasowska D; Michalska-Jakubus M; Airo P; Matucci-Cerinic M; Bruni C; Iudici M; Distler J; Gheorghiu AM; Poormoghim H; Motta F; De Santis M; Parvu M; Distler O; Mihai C Eur J Intern Med; 2024 Jul; 125():104-110. PubMed ID: 38599922 [TBL] [Abstract][Full Text] [Related]
16. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. Ceribelli A; Cavazzana I; Franceschini F; Airò P; Tincani A; Cattaneo R; Pauley BA; Chan EK; Satoh M J Rheumatol; 2010 Oct; 37(10):2071-5. PubMed ID: 20682663 [TBL] [Abstract][Full Text] [Related]
17. Strong Association of the Myriad Discrete Speckled Nuclear Pattern With Anti-SS-A/Ro60 Antibodies: Consensus Experience of Four International Expert Centers. Röber N; Dellavance A; Ingénito F; Reimer ML; Carballo OG; Conrad K; Chan EKL; Andrade LEC Front Immunol; 2021; 12():730102. PubMed ID: 34675922 [TBL] [Abstract][Full Text] [Related]
18. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289 [TBL] [Abstract][Full Text] [Related]
19. Antinucleolar antibodies and their disease association. Janwityanuchit S; Vanichapuntu M; Verasertniyom O; Totemchokchyakarn K; Vatanasuk M Asian Pac J Allergy Immunol; 1994 Jun; 12(1):43-9. PubMed ID: 7532942 [TBL] [Abstract][Full Text] [Related]
20. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]